Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.

Kokabi, Nima

Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. [electronic resource] - Cancer Jul 2015 - 2164-74 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1097-0142

10.1002/cncr.29275 doi


Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular--pathology
Disease Progression
Embolization, Therapeutic--adverse effects
Female
Humans
Liver Neoplasms--pathology
Male
Middle Aged
Portal Vein--pathology
Prognosis
Prospective Studies
Treatment Outcome
Venous Thrombosis--pathology
Yttrium Radioisotopes--administration & dosage